Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies
Olamiju B, Bhullar S, Coleman EL, Leventhal JS. Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies. Journal Of The American Academy Of Dermatology 2020, 84: 806-808. PMID: 32526318, DOI: 10.1016/j.jaad.2020.06.010.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, TopicalAdrenergic beta-AntagonistsAgedAngiolymphoid Hyperplasia with EosinophiliaAnti-Bacterial AgentsAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyCryotherapyErbB ReceptorsFemaleHead and Neck NeoplasmsHumansLung NeoplasmsMaleMiddle AgedParonychiaProtein Kinase InhibitorsRetrospective StudiesSeverity of Illness IndexSilver NitrateTimololTreatment Outcome